Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
MACF1	23499	broad.mit.edu	37	1	39761487	39761487	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	g.chr1:39761487T>G	ENST00000564288.1	+	20	3065	c.2288T>G	c.(2287-2289)tTg>tGg	p.L763W	MACF1_ENST00000539005.1_Missense_Mutation_p.L768W|MACF1_ENST00000545844.1_Missense_Mutation_p.L768W|MACF1_ENST00000567887.1_Missense_Mutation_p.L800W|MACF1_ENST00000361689.2_Missense_Mutation_p.L768W|MACF1_ENST00000372915.3_Missense_Mutation_p.L768W|MACF1_ENST00000317713.7_Missense_Mutation_p.L768W			Q9UPN3	MACF1_HUMAN	microtubule-actin crosslinking factor 1	768		NA		NA	cell cycle arrest|Golgi to plasma membrane protein transport|positive regulation of Wnt receptor signaling pathway|regulation of epithelial cell migration|regulation of focal adhesion assembly|regulation of microtubule-based process|Wnt receptor signaling pathway|wound healing	Golgi apparatus|microtubule|ruffle membrane	actin filament binding|ATPase activity|calcium ion binding|microtubule binding			breast(11)|central_nervous_system(5)|endometrium(18)|haematopoietic_and_lymphoid_tissue(1)|kidney(11)|large_intestine(36)|lung(78)|ovary(12)|prostate(2)|skin(9)|stomach(2)|upper_aerodigestive_tract(8)|urinary_tract(10)	203	Lung NSC(20;5.57e-06)|Ovarian(52;0.00769)|Acute lymphoblastic leukemia(166;0.074)	Myeloproliferative disorder(586;0.0255)	OV - Ovarian serous cystadenocarcinoma(33;7.78e-19)|Epithelial(16;1.73e-17)|all cancers(16;2.49e-16)|LUSC - Lung squamous cell carcinoma(16;0.00146)|Lung(16;0.00204)			CAGTCCCAGTTGCAGTGGATG	0.433		NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													368	305	327	NA		NA	NA	1		NA											NA				39761487		2203	4300	6503	SO:0001583	missense			ENSG00000127603	HGNC:13664	NM_033044	Approved	uc031pmc.1	NA	E9PJT0|O75053|Q5VW20|Q8WXY2|Q9H540|Q9UKP0|Q9ULG9	ENST00000564288.1	37		.	.	.	.	.	.	.	.	.	.	T	7.280	0.608970	0.14066	.	.	ENSG00000127603	ENST00000545844;ENST00000372915;ENST00000361689;ENST00000317713;ENST00000539005;ENST00000524432;ENST00000530262;ENST00000372900	D;D;D;D;D;D;D	0.93604	-3.25;-3.25;-3.25;-3.25;-3.25;-3.25;-3.25	5.65	4.56	0.56223	.	.	.	.	.	T	0.63367	0.2505	N	0.00010	-3.045	0.80722	D	1	B;B	0.06786	0.0;0.001	B;B	0.10450	0.001;0.005	T	0.73275	-0.4034	9	0.02654	T	1	.	10.8253	0.46629	0.0:0.0:0.4005:0.5995	.	768;733	F8W8Q1;Q9UPN3-3	.;.	W	768;768;768;768;768;726;917;928	ENSP00000439537:L768W;ENSP00000362006:L768W;ENSP00000354573:L768W;ENSP00000313438:L768W;ENSP00000444364:L768W;ENSP00000435070:L726W;ENSP00000437059:L917W	ENSP00000313438:L768W	L	+	2	0	MACF1	39534074	1.000000	0.71417	0.965000	0.40720	0.922000	0.55478	7.271000	0.78506	2.149000	0.67028	0.533000	0.62120	TTG	MACF1-032	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000423089.1	49.875352	KEEP		+	53.683103	0.246154	16	49	---	---	---	---	1	0.8784665	5	9	0	62	18	56	0	62	2	0	0	0	0	0	0	18	56	0	62	2	TP
SELRC1	65260	broad.mit.edu	37	1	53158443	53158443	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	g.chr1:53158443C>T	ENST00000371538.3	-	2	242	c.203G>A	c.(202-204)aGt>aAt	p.S68N	SELRC1_ENST00000486918.1_5'UTR	NM_023077.2	NP_075565.2	Q96BR5	SELR1_HUMAN	Sel1 repeat containing 1	68		NA		NA			binding			breast(1)|lung(3)|prostate(1)|urinary_tract(1)	6						GCAGCTATCACTGTGCTGGTT	0.502		NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													134	132	132	NA		NA	NA	1		NA											NA				53158443		2203	4300	6503	SO:0001583	missense			ENSG00000162377	HGNC:25716	NM_023077	Approved	uc001cui.2	NA	Q0P6I7|Q9H9Z9	ENST00000371538.3	37	CCDS570.1	.	.	.	.	.	.	.	.	.	.	C	14.98	2.697954	0.48307	.	.	ENSG00000162377	ENST00000371538	T	0.51071	0.72	6.0	5.04	0.67666	Tetratricopeptide-like helical (1);	0.183708	0.64402	D	0.000017	T	0.52500	0.1738	M	0.66939	2.045	0.35171	D	0.771558	B	0.31459	0.324	B	0.36534	0.227	T	0.65047	-0.6263	10	0.59425	D	0.04	-12.4389	16.7532	0.85492	0.0:0.8711:0.1289:0.0	.	68	Q96BR5	SELR1_HUMAN	N	68	ENSP00000360593:S68N	ENSP00000360593:S68N	S	-	2	0	SELRC1	52931031	0.997000	0.39634	0.968000	0.41197	0.376000	0.30014	3.194000	0.51005	2.848000	0.98002	0.655000	0.94253	AGT	SELRC1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000023462.1	84.607681	KEEP		-	92.820031	0.242647	33	103	---	---	---	---	1	0.9999997	31	52	0	93	37	119	0	93	2	0	0	0	0	0	0	37	119	0	93	2	TP
IDH1	3417	broad.mit.edu	37	2	209113113	209113113	+	Missense_Mutation	SNP	G	G	C	rs121913499		GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	g.chr2:209113113G>C	ENST00000415913.1	-	4	775	c.394C>G	c.(394-396)Cgt>Ggt	p.R132G	IDH1_ENST00000446179.1_Missense_Mutation_p.R132G|IDH1_ENST00000345146.2_Missense_Mutation_p.R132G			O75874	IDHC_HUMAN	isocitrate dehydrogenase 1 (NADP+), soluble	132		NA	R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).	NA	2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle	cytosol|peroxisomal matrix	isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity	p.R132C(446)|p.R132G(125)|p.R132S(106)|p.G131_R132>VL(1)|p.R132V(1)		NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1)	4887				Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136)		TAAGCATGACGACCTATGATG	0.398		NA	Mis		gliobastoma		NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(158;264 1958 3300 35450 36047)		Dom	yes		2	2q33.3	3417	"""isocitrate dehydrogenase 1 (NADP+), soluble"""	NA	O	679	Substitution - Missense(678)|Complex - compound substitution(1)	haematopoietic_and_lymphoid_tissue(280)|central_nervous_system(181)|bone(177)|biliary_tract(21)|soft_tissue(12)|large_intestine(2)|skin(2)|autonomic_ganglia(1)|endometrium(1)|NS(1)|prostate(1)											81	74	76	NA		NA	NA	2		NA											NA				209113113		2203	4300	6503	SO:0001583	missense			ENSG00000138413	HGNC:5382		Approved	uc002vcu.3	NA	Q7Z3V0|Q93090|Q9NTJ9|Q9UKW8	ENST00000415913.1	37	CCDS2381.1	.	.	.	.	.	.	.	.	.	.	G	22.4	4.286370	0.80803	.	.	ENSG00000138413	ENST00000345146;ENST00000446179;ENST00000415913;ENST00000415282	D;D;D;D	0.86956	-2.19;-2.19;-2.19;-2.19	5.57	5.57	0.84162	Isopropylmalate dehydrogenase-like domain (2);	0.000000	0.85682	D	0.000000	D	0.96636	0.8902	H	0.99379	4.54	0.80722	D	1	D	0.57899	0.981	P	0.62813	0.907	D	0.98312	1.0524	10	0.87932	D	0	-20.0399	19.5341	0.95242	0.0:0.0:1.0:0.0	.	132	O75874	IDHC_HUMAN	G	132	ENSP00000260985:R132G;ENSP00000410513:R132G;ENSP00000390265:R132G;ENSP00000391075:R132G	ENSP00000260985:R132G	R	-	1	0	IDH1	208821358	1.000000	0.71417	0.999000	0.59377	0.994000	0.84299	7.074000	0.76791	2.616000	0.88540	0.555000	0.69702	CGT	IDH1-006	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336672.1	77.410847	KEEP		-	78.861574	0.343284	23	44	---	---	---	---	1	1	116	144	0	102	24	56	0	102	2	1	1	29	100	0	5	24	56	0	102	2	TP
WDR1	9948	broad.mit.edu	37	4	10080542	10080542	+	Silent	SNP	G	G	A			GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	g.chr4:10080542G>A	ENST00000382452.2	-	12	1650	c.1368C>T	c.(1366-1368)ggC>ggT	p.G456G	WDR1_ENST00000515743.1_5'UTR|WDR1_ENST00000382451.2_Silent_p.G316G|MIR3138_ENST00000585238.1_RNA|WDR1_ENST00000502702.1_Silent_p.G316G|WDR1_ENST00000499869.2_Silent_p.G456G	NM_017491.3	NP_059830.1	O75083	WDR1_HUMAN	WD repeat domain 1	456		NA		NA	platelet activation|platelet degranulation|sensory perception of sound	cytoskeleton|cytosol|extracellular region	actin binding			endometrium(3)|lung(5)|ovary(2)|pancreas(1)|urinary_tract(1)	12				STAD - Stomach adenocarcinoma(129;0.000703)|Colorectal(103;0.0057)|LUSC - Lung squamous cell carcinoma(721;0.0232)		CCGTGTCCCCGCCGGGGTGCA	0.592		NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													74	90	85	NA		NA	NA	4		NA											NA				10080542		2000	4163	6163	SO:0001819	synonymous_variant			ENSG00000071127	HGNC:12754		Approved	uc021xlv.1	NA	A8K6E9|A8MPU4|O75313|Q8N6E5|Q9UG05|Q9UG78|Q9UQE0	ENST00000382452.2	37																																																																																				WDR1-202	KNOWN	basic	protein_coding	NA	protein_coding		41.036281	KEEP		-	44.838655	0.25	17	51	---	---	---	---	1	1	237	525	0	59	20	63	0	59	2	0	0	0	0	0	0	20	63	0	59	2	TP
NFKB1	4790	broad.mit.edu	37	4	103518775	103518775	+	Missense_Mutation	SNP	G	G	A	rs139575566		GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	g.chr4:103518775G>A	ENST00000226574.4	+	15	2061	c.1594G>A	c.(1594-1596)Gtc>Atc	p.V532I	NFKB1_ENST00000600343.1_Missense_Mutation_p.V351I|NFKB1_ENST00000505458.1_Missense_Mutation_p.V531I|NFKB1_ENST00000394820.4_Missense_Mutation_p.V531I	NM_001165412.1|NM_003998.3	NP_001158884.1|NP_003989.2	P19838	NFKB1_HUMAN	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1	531	Interaction with CFLAR.	NA		NA	anti-apoptosis|apoptosis|cellular response to mechanical stimulus|inflammatory response|innate immune response|membrane protein intracellular domain proteolysis|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|negative regulation of calcidiol 1-monooxygenase activity|nerve growth factor receptor signaling pathway|positive regulation of canonical Wnt receptor signaling pathway|positive regulation of NF-kappaB transcription factor activity|positive regulation of transcription, DNA-dependent|T cell receptor signaling pathway|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|transcription from RNA polymerase II promoter	cytosol|I-kappaB/NF-kappaB complex|mitochondrion|nucleoplasm	protein binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding	p.V532I(1)		biliary_tract(1)|breast(4)|endometrium(2)|large_intestine(6)|lung(7)|ovary(2)|skin(4)|upper_aerodigestive_tract(1)	27		Hepatocellular(203;0.217)		OV - Ovarian serous cystadenocarcinoma(123;6.59e-08)	Dexamethasone(DB01234)|Pranlukast(DB01411)|Thalidomide(DB01041)	GCTGCTGGCCGTCCAGCGCCA	0.522		NA					NA				NA	NA	G	2	9e-04	NA	NA	2184	0.0017	0.9999	,	,	NA	5e-04	0.0013	NA	NA	0.001	0.9547	EXOME	NA	NA	3e-04	SNP						NA		NA		NA		1	Substitution - Missense(1)	breast(1)						G	ILE/VAL,ILE/VAL	0,4406		0,0,2203	115	102	107	NA	1591,1594	4.6	1	4	dbSNP_134	107	1,8599	1.2+/-3.3	0,1,4299	no	missense,missense	NFKB1	NM_001165412.1,NM_003998.3	29,29	0,1,6502	AA,AG,GG	NA	0.0116,0.0,0.0077	possibly-damaging,possibly-damaging	531/969,532/970	103518775	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000109320	HGNC:7794		Approved	uc011cep.2	NA	Q68D84|Q86V43|Q8N4X7|Q9NZC0	ENST00000226574.4	37	CCDS3657.1	2	9.157509157509158E-4	0	0.0	0	0.0	1	0.0017482517482517483	1	0.0013192612137203166	G	15.05	2.717020	0.48622	0.0	1.16E-4	ENSG00000109320	ENST00000226574;ENST00000394820;ENST00000505458	T;T;T	0.63913	-0.07;-0.07;-0.07	4.64	4.64	0.57946	Ankyrin repeat-containing domain (1);	0.252545	0.32687	N	0.005763	T	0.69052	0.3068	M	0.63428	1.95	0.35903	D	0.830515	D;P;D	0.65815	0.966;0.922;0.995	B;B;P	0.52710	0.312;0.266;0.707	T	0.72571	-0.4253	10	0.23302	T	0.38	.	17.7248	0.88362	0.0:0.0:1.0:0.0	.	351;531;532	B3KVE8;P19838;P19838-2	.;NFKB1_HUMAN;.	I	532;531;531	ENSP00000226574:V532I;ENSP00000378297:V531I;ENSP00000424790:V531I	ENSP00000226574:V532I	V	+	1	0	NFKB1	103737813	1.000000	0.71417	0.969000	0.41365	0.996000	0.88848	3.529000	0.53532	2.419000	0.82065	0.655000	0.94253	GTC	NFKB1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253801.1	42.582157	KEEP		+	49.722064	0.208791	19	72	---	---	---	---	1	0.9999997	33	84	0	90	20	78	0	90	2	0	0	0	0	0	0	20	78	0	90	2	TP
GRINA	2907	broad.mit.edu	37	8	145065758	145065758	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	g.chr8:145065758C>G	ENST00000313269.5	+	2	645	c.367C>G	c.(367-369)Caa>Gaa	p.Q123E	GRINA_ENST00000395068.4_Missense_Mutation_p.Q123E	NM_000837.1	NP_000828.1	Q7Z429	GRINA_HUMAN	glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)	123	Pro-rich.	NA		NA		integral to membrane				central_nervous_system(1)|cervix(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(2)|skin(1)|stomach(1)	9	all_cancers(97;8.2e-11)|all_epithelial(106;1.1e-09)|Lung NSC(106;5.89e-05)|all_lung(105;0.000174)|Ovarian(258;0.0173)|Acute lymphoblastic leukemia(118;0.155)		OV - Ovarian serous cystadenocarcinoma(54;1.31e-40)|Epithelial(56;1.16e-39)|all cancers(56;6.43e-35)|Colorectal(110;0.055)|BRCA - Breast invasive adenocarcinoma(115;0.105)			CTTCCCAGGACAAGACCCTGA	0.672		NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													17	21	20	NA		NA	NA	8		NA											NA				145065758		2073	4226	6299	SO:0001583	missense				HGNC:4589	NM_001009184	Approved	uc003zao.1	NA	B3KXM7|O43836|Q8IVW7	ENST00000313269.5	37	CCDS34961.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	9.915|9.915	1.210526|1.210526	0.22289|0.22289	.|.	.|.	ENSG00000178719|ENSG00000178719	ENST00000313269;ENST00000529301;ENST00000395068;ENST00000537637|ENST00000534791;ENST00000533044	T;T;T|.	0.22336|.	1.98;1.96;1.98|.	4.33|4.33	3.41|3.41	0.39046|0.39046	.|.	3.431410|.	0.00794|.	N|.	0.001373|.	T|T	0.29882|0.29882	0.0747|0.0747	N|N	0.17723|0.17723	0.515|0.515	0.24248|0.24248	N|N	0.995337|0.995337	B|.	0.16166|.	0.016|.	B|.	0.18871|.	0.023|.	T|T	0.18777|0.18777	-1.0326|-1.0326	10|5	0.21540|.	T|.	0.41|.	-0.6188|-0.6188	9.7977|9.7977	0.40744|0.40744	0.2067:0.7933:0.0:0.0|0.2067:0.7933:0.0:0.0	.|.	123|.	Q7Z429|.	GRINA_HUMAN|.	E|R	123;123;123;104|46;12	ENSP00000314380:Q123E;ENSP00000432706:Q123E;ENSP00000378507:Q123E|.	ENSP00000314380:Q123E|.	Q|T	+|+	1|2	0|0	GRINA|GRINA	145137746|145137746	0.821000|0.821000	0.29204|0.29204	0.094000|0.094000	0.20943|0.20943	0.476000|0.476000	0.33039|0.33039	2.398000|2.398000	0.44486|0.44486	1.075000|1.075000	0.40932|0.40932	0.585000|0.585000	0.79938|0.79938	CAA|ACA	GRINA-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000384048.1	22.706298	KEEP		+	29.926036	0.15625	10	54	---	---	---	---	1	1	332	592	0	62	12	64	0	62	2	0	0	0	0	0	0	12	64	0	62	2	TP
AMN1	196394	broad.mit.edu	37	12	31850308	31850308	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	g.chr12:31850308G>A	ENST00000281471.6	-	5	743	c.578C>T	c.(577-579)gCg>gTg	p.A193V	AMN1_ENST00000537562.1_Missense_Mutation_p.A175V|AMN1_ENST00000536761.1_Missense_Mutation_p.A175V|AMN1_ENST00000542781.1_5'UTR|AMN1_ENST00000541931.1_5'UTR	NM_001113402.1|NM_001278411.1|NM_001278412.1	NP_001106873.1|NP_001265340.1|NP_001265341.1	Q8IY45	AMN1_HUMAN	antagonist of mitotic exit network 1 homolog (S. cerevisiae)	193		NA		NA						breast(1)|endometrium(1)|large_intestine(2)|lung(1)|skin(1)|urinary_tract(1)	7	all_cancers(9;7.41e-12)|all_epithelial(9;1.18e-11)|all_lung(12;1.14e-10)|Acute lymphoblastic leukemia(23;0.0122)|Lung SC(12;0.0336)|all_hematologic(23;0.0429)|Esophageal squamous(101;0.162)		OV - Ovarian serous cystadenocarcinoma(6;0.0014)			TAATTTCTTCGCACAAGGTCC	0.338		NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													106	95	98	NA		NA	NA	12		NA											NA				31850308		1821	4092	5913	SO:0001583	missense			ENSG00000151743	HGNC:27281	NR_004854	Approved	uc001rkq.4	NA	Q6NVU4|Q86X98	ENST00000281471.6	37	CCDS44858.1	.	.	.	.	.	.	.	.	.	.	G	17.32	3.359078	0.61403	.	.	ENSG00000151743	ENST00000281471;ENST00000537562;ENST00000536761;ENST00000535408	T;T;T;T	0.17370	2.28;2.28;2.28;4.3	5.9	5.9	0.94986	.	0.148158	0.45606	D	0.000346	T	0.12347	0.0300	L	0.36672	1.1	0.80722	D	1	P	0.36483	0.555	B	0.24541	0.054	T	0.13176	-1.0519	10	0.18710	T	0.47	.	15.779	0.78246	0.0:0.0:1.0:0.0	.	193	Q8IY45	AMN1_HUMAN	V	193;175;175;175	ENSP00000281471:A193V;ENSP00000441419:A175V;ENSP00000440967:A175V;ENSP00000438990:A175V	ENSP00000281471:A193V	A	-	2	0	AMN1	31741575	1.000000	0.71417	1.000000	0.80357	0.963000	0.63663	3.565000	0.53798	2.788000	0.95919	0.650000	0.86243	GCG	AMN1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000402807.2	13.676884	KEEP		-	20.315244	0.145455	8	47	---	---	---	---	1	0.9997764	34	92	0	76	8	53	0	76	2	0	0	0	0	0	0	8	53	0	76	2	TP
MARCH9	92979	broad.mit.edu	37	12	58152585	58152585	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	g.chr12:58152585A>G	ENST00000266643.5	+	4	1377	c.946A>G	c.(946-948)Aca>Gca	p.T316A	MARCH9_ENST00000548358.1_Missense_Mutation_p.T203A	NM_138396.5	NP_612405.2	Q86YJ5	MARH9_HUMAN	membrane-associated ring finger (C3HC4) 9	316		NA		NA		Golgi membrane|Golgi stack|integral to membrane|lysosomal membrane|trans-Golgi network	ligase activity|zinc ion binding			autonomic_ganglia(1)|large_intestine(2)|lung(1)	4	all_cancers(7;4.96e-69)|Lung NSC(6;5.5e-25)|all_lung(6;3.87e-23)|all_epithelial(6;1.66e-15)|Glioma(12;6.95e-05)|all_neural(12;0.00016)|Melanoma(17;0.122)		GBM - Glioblastoma multiforme(5;4.21e-120)|all cancers(5;3.75e-83)|BRCA - Breast invasive adenocarcinoma(9;0.0294)			CTGCGGTTATACAATCTTGCA	0.652		NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													29	29	29	NA		NA	NA	12		NA											NA				58152585		2202	4300	6502	SO:0001583	missense				HGNC:25139	NM_138396	Approved	uc001spx.2	NA	B2R9U9|Q86VN5|Q96GG2	ENST00000266643.5	37	CCDS31847.1	.	.	.	.	.	.	.	.	.	.	A	18.86	3.714244	0.68730	.	.	ENSG00000139266	ENST00000266643;ENST00000548358	T;T	0.34275	2.26;1.37	5.56	5.56	0.83823	.	0.000000	0.85682	D	0.000000	T	0.58337	0.2115	M	0.68317	2.08	0.54753	D	0.999987	D;P	0.71674	0.998;0.881	D;P	0.87578	0.998;0.527	T	0.58999	-0.7536	10	0.51188	T	0.08	.	14.8138	0.70017	1.0:0.0:0.0:0.0	.	203;316	Q86YJ5-2;Q86YJ5	.;MARH9_HUMAN	A	316;203	ENSP00000266643:T316A;ENSP00000446758:T203A	ENSP00000266643:T316A	T	+	1	0	MARCH9	56438852	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	8.510000	0.90532	2.330000	0.79161	0.533000	0.62120	ACA	MARCH9-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000409244.1	24.481286	KEEP		+	33.936616	0.142857	11	66	---	---	---	---	1	0.9999844	37	121	0	34	11	72	0	34	2	0	0	0	0	0	0	11	72	0	34	2	TP
TP53	7157	broad.mit.edu	37	17	7577539	7577539	+	Missense_Mutation	SNP	G	G	A	rs121912651		GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	g.chr17:7577539G>A	ENST00000420246.2	-	7	874	c.742C>T	c.(742-744)Cgg>Tgg	p.R248W	TP53_ENST00000574684.1_5'Flank|TP53_ENST00000413465.2_Missense_Mutation_p.R248W|TP53_ENST00000269305.4_Missense_Mutation_p.R248W|TP53_ENST00000445888.2_Missense_Mutation_p.R248W|TP53_ENST00000359597.4_Missense_Mutation_p.R248W|TP53_ENST00000455263.2_Missense_Mutation_p.R248W	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	248	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Interacts with the 53BP2 SH3 domain.	NA	NR -> IP (in a sporadic cancer; somatic mutation).|NR -> KW (in sporadic cancers; somatic mutation).|R -> C (in a sporadic cancer; somatic mutation).|R -> G (in sporadic cancers; somatic mutation).|R -> L (in sporadic cancers; somatic mutation).|R -> P (in sporadic cancers; somatic mutation).|R -> Q (in LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs11540652).|R -> W (in LFS; germline mutation and in sporadic cancers; somatic mutation).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.R248W(544)|p.R155W(28)|p.R248G(12)|p.0?(8)|p.?(5)|p.N247_R248delNR(2)|p.R248fs*16(2)|p.N247_R248>KW(2)|p.M246_P250delMNRRP(2)|p.R248fs*97(2)|p.R248R(2)|p.R248fs*>39(1)|p.R248_P250delRRP(1)|p.unknown(1)|p.N247_R249delNRR(1)|p.N247_P250delNRRP(1)|p.R248C(1)|p.G245fs*14(1)|p.N247_R248>IP(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		ATGGGCCTCCGGTTCATGCCG	0.577	R248W(786O_KIDNEY)|R248W(CAS1_CENTRAL_NERVOUS_SYSTEM)|R248W(COLO320_LARGE_INTESTINE)|R248W(COLO680N_OESOPHAGUS)|R248W(DB_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248W(GCT_SOFT_TISSUE)|R248W(HCC2157_BREAST)|R248W(JIMT1_BREAST)|R248W(KO52_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248W(LUDLU1_LUNG)|R248W(LXF289_LUNG)|R248W(MIAPACA2_PANCREAS)|R248W(RD_SOFT_TISSUE)|R248W(SW837_LARGE_INTESTINE)|R248W(VCAP_PROSTATE)	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	617	Substitution - Missense(585)|Whole gene deletion(8)|Deletion - In frame(7)|Unknown(6)|Insertion - Frameshift(3)|Deletion - Frameshift(3)|Complex - compound substitution(3)|Substitution - coding silent(2)	large_intestine(156)|breast(72)|ovary(42)|endometrium(38)|oesophagus(38)|skin(37)|haematopoietic_and_lymphoid_tissue(37)|central_nervous_system(35)|stomach(27)|lung(26)|upper_aerodigestive_tract(25)|urinary_tract(19)|biliary_tract(17)|pancreas(12)|prostate(10)|soft_tissue(6)|bone(6)|thyroid(4)|liver(4)|penis(2)|peritoneum(1)|vulva(1)|kidney(1)|cervix(1)	GRCh37	CM010465|CM900211	TP53	M	rs121912651						151	112	125	NA		NA	NA	17		NA											NA				7577539		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	G	18.84	3.710019	0.68730	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944	D;D;D;D;D;D;D;D	0.99869	-7.34;-7.34;-7.34;-7.34;-7.34;-7.34;-7.34;-7.34	4.62	2.56	0.30785	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99843	0.9928	M	0.92507	3.315	0.58432	A	0.999997	D;D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D	0.97110	1.0;1.0;1.0;1.0;1.0;1.0	D	0.97208	0.9869	9	0.87932	D	0	-9.5643	7.568	0.27890	0.0893:0.0:0.7471:0.1636	.	248;248;155;248;248;248	P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;P53_HUMAN;.;.	W	248;248;248;248;248;248;237;155;116;155	ENSP00000410739:R248W;ENSP00000352610:R248W;ENSP00000269305:R248W;ENSP00000398846:R248W;ENSP00000391127:R248W;ENSP00000391478:R248W;ENSP00000425104:R116W;ENSP00000423862:R155W	ENSP00000269305:R248W	R	-	1	2	TP53	7518264	1.000000	0.71417	1.000000	0.80357	0.910000	0.53928	1.447000	0.35101	0.644000	0.30656	0.462000	0.41574	CGG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	134.779548	KEEP		-	134.824206	0.525641	41	37	---	---	---	---	1	1	201	40	0	88	51	49	0	88	2	1	1	3469	2919	5	6793	51	49	0	88	28	TP
COLEC12	81035	broad.mit.edu	37	18	334801	334801	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-15-1444-Tumor-SM-1Y49O	GBM-TCGA-15-1444-Normal-SM-1Y49J	g.chr18:334801G>A	ENST00000400256.3	-	6	1964	c.1757C>T	c.(1756-1758)tCa>tTa	p.S586L		NM_130386.2	NP_569057.1	Q5KU26	COL12_HUMAN	collectin sub-family member 12	586	Collagen-like 3.	NA		NA	carbohydrate mediated signaling|innate immune response|phagocytosis, recognition|protein homooligomerization	collagen|integral to membrane	galactose binding|low-density lipoprotein particle binding|metal ion binding|pattern recognition receptor activity|scavenger receptor activity			cervix(2)|endometrium(3)|kidney(2)|large_intestine(10)|lung(21)|ovary(2)|pancreas(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(2)	46		all_cancers(4;0.0442)|Myeloproliferative disorder(11;0.0426)				CACCGCTCCTGATGGGCCAGG	0.701		NA					NA				NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0													25	24	25	NA		NA	NA	18		NA											NA				334801		2203	4299	6502	SO:0001583	missense			ENSG00000158270	HGNC:16016		Approved	uc002kkm.3	NA	Q6P9F2|Q8TCR2|Q8WZA4|Q9BY85|Q9BYH7	ENST00000400256.3	37	CCDS32782.1	.	.	.	.	.	.	.	.	.	.	G	13.38	2.221175	0.39201	.	.	ENSG00000158270	ENST00000400256	D	0.93133	-3.17	5.26	4.38	0.52667	.	0.695945	0.13908	N	0.354441	D	0.87716	0.6247	N	0.25332	0.735	0.19300	N	0.999977	B	0.16396	0.017	B	0.20184	0.028	T	0.77742	-0.2474	10	0.38643	T	0.18	-0.7109	8.8654	0.35282	0.0748:0.0:0.7753:0.1499	.	586	Q5KU26	COL12_HUMAN	L	586	ENSP00000383115:S586L	ENSP00000383115:S586L	S	-	2	0	COLEC12	324801	1.000000	0.71417	0.030000	0.17652	0.137000	0.21094	4.553000	0.60753	1.192000	0.43071	0.462000	0.41574	TCA	COLEC12-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000440746.1	31.183528	KEEP		-	32.332032	0.315789	12	26	---	---	---	---	1	0.9986562	5	24	0	38	14	29	0	38	2	0	0	0	0	0	0	14	29	0	38	2	TP
